Document Detail


Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
MedLine Citation:
PMID:  23051178     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background  Gut-directed hypnotherapy is an effective treatment option for irritable bowel syndrome (IBS). However, clinical observations suggest that patient satisfaction with hypnotherapy is not always associated with improvement in IBS symptoms. Methods  We evaluated 83 patients with IBS treated with gut-directed hypnotherapy (1 h week(-1) , 12 weeks). After the treatment period, patients reported their satisfaction with the treatment (ranging from 1 = not at all satisfied, to 5 = very satisfied) and completed questionnaires to assess IBS symptom severity, quality of life, cognitive function, sense of coherence, depression, and anxiety before and after treatment. Key Results  After hypnotherapy improved IBS symptom severity, quality of life, cognitive function, and anxiety were seen. Thirty patients (36%) were very satisfied with the treatment and 57 (69%) patients scored 4 or 5 on the patient satisfaction scale. Patient satisfaction was associated with less severe IBS symptoms and better quality of life after the treatment. In a multiple linear regression analysis, only the quality of life domain sexual relations was independently associated with patient satisfaction after hypnotherapy, explaining 22% of the variance. Using 25% reduction of IBS symptom severity to define an IBS symptom responder, 52% of the responders were very satisfied with hypnotherapy, but this was also true for 31% in the non-responder group. Conclusions & Inferences  Patient satisfaction with gut-directed hypnotherapy in IBS is associated with improvement of quality of life and gastrointestinal (GI) symptoms. However, other factors unrelated to GI symptoms also seems to be of importance for patient satisfaction, as a substantial proportion of patients without GI symptom improvement were also very satisfied with this treatment option.
Authors:
P Lindfors; B Ljótsson; E Bjornsson; H Abrahamsson; M Simrén
Related Documents :
23136828 - Is there sufficient evidence to support the long-term efficacy of mineral trioxide aggr...
24693328 - Sanqi panax notoginseng injection for angina pectoris.
23017618 - Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-...
23506328 - Telehealth group interactions in the hospice setting: assessing technical quality acros...
19467158 - Influence of horse stable environment on human airways.
2012458 - Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessa...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-11
Journal Detail:
Title:  Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society     Volume:  -     ISSN:  1365-2982     ISO Abbreviation:  Neurogastroenterol. Motil.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9432572     Medline TA:  Neurogastroenterol Motil     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 Blackwell Publishing Ltd.
Affiliation:
Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Department of Gastroenterology, Sabbatsbergs Hospital, Stockholm, Sweden Department of Clinical Neuroscience, Section of Psychology, Karolinska Institutet, Stockholm, Sweden Centre for Person-Centred Care (GPCC), Sahlgrenska Academy, University of Gothenburg, University of Gothenburg, Gothenburg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Health service utilization by indigenous cancer patients in Queensland: a descriptive study.
Next Document:  Viral infections and molecular mimicry in type 1 diabetes.